Citation Impact

Citing Papers

A myocardium tropic adeno-associated virus (AAV) evolved by DNA shuffling and in vivo selection
2009
A Novel Germline Variant in CSF3R Reduces N-Glycosylation and Exerts Potent Oncogenic Effects in Leukemia
2018 StandoutNobel
Efficacy of Intermittent Combined RAF and MEK Inhibition in a Patient with Concurrent BRAF- and NRAS-Mutant Malignancies
2014
Validation of a Prognostic Model and the Impact of Mutations in Patients With Lower-Risk Myelodysplastic Syndromes
2012
Arid5a Promotes Immune Evasion by Augmenting Tryptophan Metabolism and Chemokine Expression
2021 StandoutNobel
Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
2022 Standout
Cytogenetic and molecular abnormalities in chronic myelomonocytic leukemia
2016
Thermal Stability as a Determinant of AAV Serotype Identity
2017
Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes
2017
Convection-enhanced delivery and systemic mannitol increase gene product distribution of AAV vectors 5, 8, and 9 and increase gene product in the adult mouse brain
2010
Superior In vivo Transduction of Human Hepatocytes Using Engineered AAV3 Capsid
2016 StandoutNobel
In Vivo Selection Yields AAV-B1 Capsid for Central Nervous System and Muscle Gene Therapy
2016
Parvovirus glycan interactions
2014
A view on drug resistance in cancer
2019 StandoutNature
Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial
2016 Standout
AAV Capsid Structure and Cell Interactions
2011
Non-uniform refinement: adaptive regularization improves single-particle cryo-EM reconstruction
2020 Standout
Targeting the IDO1/TDO2–KYN–AhR Pathway for Cancer Immunotherapy – Challenges and Opportunities
2017
Innovation by homologous recombination
2013 StandoutNobel
Amyloid Oligomers Exacerbate Tau Pathology in a Mouse Model of Tauopathy
2012 Standout
Adeno-associated virus (AAV) capsid genes isolated from rat and mouse liver genomic DNA define two new AAV species distantly related to AAV-5
2006
The NLRP3 inflammasome: molecular activation and regulation to therapeutics
2019 Standout
Ocular Drug Delivery
2010 Standout
Macrophages in immunoregulation and therapeutics
2023 Standout
The changing landscape of atherosclerosis
2021 StandoutNature
Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities
2021 Standout
Biological roles of glycans
2016 Standout
Targeting the NLRP3 inflammasome in inflammatory diseases
2018
Evolution of a designed protein assembly encapsulating its own RNA genome
2017 StandoutNatureNobel
GSK3 Deficiencies in Hematopoietic Stem Cells Initiate Pre-neoplastic State that Is Predictive of Clinical Outcomes of Human Acute Leukemia
2016
CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia
2013
Clonal Hematopoiesis and Evolution to Hematopoietic Malignancies
2018
Lower limb cellulitis and its mimics
2012
The Role of β-Hemolytic Streptococci in Causing Diffuse, Nonculturable Cellulitis
2010
Reengineering a receptor footprint of adeno-associated virus enables selective and systemic gene transfer to muscle
2009
Sialic acid-specific lectins: occurrence, specificity and function
2006
Hematopoietic progenitor cells as integrative hubs for adaptation to and fine-tuning of inflammation
2019
Germline viral “fossils” guide in silico reconstruction of a mid-Cenozoic era marsupial adeno-associated virus
2016
AAV Hybrid Serotypes: Improved Vectors for Gene Delivery
2005
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
2018 Standout
An International MDS/MPN Working Group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/myeloproliferative neoplasms
2015
DNA Shuffling of Adeno-associated Virus Yields Functionally Diverse Viral Progeny
2008
Vector Design Tour de Force: Integrating Combinatorial and Rational Approaches to Derive Novel Adeno-associated Virus Variants
2014
Sickle-cell disease
2010 Standout
The AAV Vector Toolkit: Poised at the Clinical Crossroads
2012
Adeno-associated virus vector as a platform for gene therapy delivery
2019 Standout
The Emerging Hallmarks of Cancer Metabolism
2016 Standout
Phase 1 Gene Therapy for Duchenne Muscular Dystrophy Using a Translational Optimized AAV Vector
2011
ResLog plots as an empirical metric of the quality of cryo-EM reconstructions
2014
<p>GM-CSF: A Promising Target in Inflammation and Autoimmunity</p>
2020
Comparative Study of Liver Gene Transfer With AAV Vectors Based on Natural and Engineered AAV Capsids
2015
Optimization of the Capsid of Recombinant Adeno-Associated Virus 2 (AAV2) Vectors: The Final Threshold?
2013
Clonal Hematopoiesis
2019
Defining trained immunity and its role in health and disease
2020 Standout
Trial watch: IDO inhibitors in cancer therapy
2014
Down syndrome
2020 Standout
Optogenetics in Neural Systems
2011 Standout
Tumour heterogeneity and resistance to cancer therapies
2017 Standout
Clinical and genetic predictors of prognosis in myelodysplastic syndromes
2014
Safe and Effective In Vivo Targeting and Gene Editing in Hematopoietic Stem Cells: Strategies for Accelerating Development
2021 StandoutNobel
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Management of Skin and Soft-Tissue Infection
2008
Recent developments in myelodysplastic syndromes
2014
Chronic Myelomonocytic Leukemia
2016
Results of a phase 2 study of pacritinib (SB1518), a JAK2/JAK2(V617F) inhibitor, in patients with myelofibrosis
2015
JAK2 inhibitors for myeloproliferative neoplasms: what is next?
2017
Molecular and prognostic correlates of cytogenetic abnormalities in chronic myelomonocytic leukemia: a Mayo Clinic‐French Consortium Study
2014
Parvovirus Family Conundrum: What Makes a Killer?
2015
Cryo-electron Microscopy Reconstruction and Stability Studies of the Wild Type and the R432A Variant of Adeno-associated Virus Type 2 Reveal that Capsid Structural Stability Is a Major Factor in Genome Packaging
2016
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
2011 Standout
Capsid Antibodies to Different Adeno-Associated Virus Serotypes Bind Common Regions
2013
Intratumoral activation of the necroptotic pathway components RIPK1 and RIPK3 potentiates antitumor immunity
2019 StandoutNobel
International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes
1997 Standout
The emerging role of immune checkpoint based approaches in AML and MDS
2017 StandoutNobel
DAMP-sensing receptors in sterile inflammation and inflammatory diseases
2019 Standout
Trisomy 21 consistently activates the interferon response
2016
Adeno-Associated Virus Structural Biology as a Tool in Vector Development
2013
New Parvovirus Associated with Serum Hepatitis in Horses after Inoculation of Common Biological Product
2018 StandoutNobel
How I treat transfusional iron overload
2012
SCHEMA Computational Design of Virus Capsid Chimeras: Calibrating How Genome Packaging, Protection, and Transduction Correlate with Calculated Structural Disruption
2013
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
2015 Standout
Imaging the glycome
2008 StandoutNobel
Community-Associated Methicillin-ResistantStaphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic
2010 Standout
Coevolution of Adeno-associated Virus Capsid Antigenicity and Tropism through a Structure-Guided Approach
2020
Comparative Analysis of Adeno-Associated Virus Capsid Stability and Dynamics
2013
Treatment options for patients with myelodysplastic syndromes after hypomethylating agent failure
2016
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
Resolving Adeno-Associated Viral Particle Diversity With Charge Detection Mass Spectrometry
2016

Works of Eric Padron being referenced

A Multi-Institution Phase I Trial of Ruxolitinib in Patients with Chronic Myelomonocytic Leukemia (CMML)
2016
Validation of the MD Anderson Prognostic Risk Model for patients with myelodysplastic syndrome
2011
Production, purification and preliminary X-ray crystallographic studies of adeno-associated virus serotype 4
2003
Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomes
2013
Chronic myelomonocytic leukemia in younger patients: molecular and cytogenetic predictors of survival and treatment outcome
2015
Risk factors for bacteremia in patients with limb cellulitis
2006
A Phase II Study to Determine the Safety and Efficacy of the Oral Inhibitor of Indoleamine 2,3-Dioxygenase (IDO) Enzyme INCB024360 in Patients with Myelodysplastic Syndromes
2018
The molecular basis and clinical significance of genetic mutations identified in myelodysplastic syndromes
2014
Validation of the Lower-Risk MD Anderson Prognostic Scoring System for Patients With Myelodysplastic Syndrome
2015
Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case-control study
2016
Production, purification, crystallization and preliminary X-ray analysis of adeno-associated virus serotype 8
2005
Structure of Adeno-Associated Virus Serotype 8, a Gene Therapy Vector
2007
Validation of the Lower Risk MD Anderson Prognostic Scoring System for Patients with Myelodysplastic Syndromes
2012
Structurally Mapping the Diverse Phenotype of Adeno-Associated Virus Serotype 4
2006
Validation of the revised International Prognostic Scoring System in treated patients with myelodysplastic syndromes
2013
Phase 1 study of lenzilumab, a recombinant anti–human GM-CSF antibody, for chronic myelomonocytic leukemia
2020
Managing Clonal Hematopoiesis in Patients With Solid Tumors
2018
Outcome of patients with low‐risk and intermediate‐1‐risk myelodysplastic syndrome after hypomethylating agent failure: A report on behalf of the MDS Clinical Research Consortium
2014
Structure of Adeno-Associated Virus Type 4
2005
Outcome Of Patients (pts) With Low and Intermediate-1 Risk Myelodysplastic Syndrome (MDS) After Hypomethylating Agent (HMA) Failure
2013
Advances in the Management of Myelofibrosis
2012
A Phase II Study to Determine the Safety and Efficacy of the Oral Inhibitor of Indoleamine 2,3-Dioxygenase (IDO) Enzyme INCB024360 in Patients with Myelodysplastic Syndromes
2014
Impact of Iron Chelation Therapy on Overall Survival and AML Transformation in Lower Risk MDS Patients Treated At the Moffitt Cancer Center
2011
The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotype
2016
GM-CSF–dependent pSTAT5 sensitivity is a feature with therapeutic potential in chronic myelomonocytic leukemia
2013
Rankless by CCL
2026